L Xiong, XM Lin, JH Nie, HS Ye, J Liu - Nanotheranostics, 2021 - ncbi.nlm.nih.gov
Background: Docetaxel and doxorubicin combination has been widely used in anaplastic
thyroid cancer/ATC treatment but often results in serious adverse effects and drug …